Blog | Oncotarget

EMT Resistance in Cancer Cells and Two Potential Causes

Researchers used mathematical modeling to investigate mechanisms that drive the elusive phenomenon of cancer cell... read more

By Kathryn Atkins October 21, 2021

Ataxia telangiectasia and Rad3 (ATR) inhibition was targeted in an attempt to overcome temozolomide (TMZ)... read more

By Kathryn Atkins October 13, 2021

Read short summaries of the latest oncology-focused research published in this week’s issue of&... read more

By Oncotarget October 12, 2021

Researchers repurposed CRISPR/Cas9 epigenetic editing technology in hopes of characterizing transcriptional changes and effects... read more

By Kathryn Atkins October 5, 2021

In a trending paper published by Oncotarget, researchers developed a divergent strategy to treat non-small... read more

By Kathryn Atkins September 30, 2021

Researchers discovered an enzyme, originally known to regulate the TGF-β, has a previously unreported role... read more

By Kathryn Atkins September 30, 2021

Read short summaries of the latest oncology-focused research published in this week’s issue of... read more

By Oncotarget September 28, 2021

Dr. Herbert Levine and Dr. Mohit Kumar Jolly describe their research that... read more

By Oncotarget September 27, 2021

The mechanism(s) by which a nutrigenetic compound exerts its therapeutic effect on bronchial carcinoid... read more

By Kathryn Atkins September 21, 2021

Dr. Yves Chabu from the Department of Biological Sciences at the University of Missouri describes... read more

By Oncotarget September 20, 2021